Is Zenotech Laboratories a good stock to invest in?

Zenotech Laboratories can be analyzed on the following key metrics - TTM P/E: - Sector P/E: 29.76 Dividend Yield: - D/E ratio: -

Zenotech Laboratories Share Price

Sector: Biotechnology & Drugs

Powered by

76.20 +0.10 (0.13%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 74.5

Today’s High 77.9

52 Week Low 52.23

52 Week High 107.79

Key Metrics

Sector P/E 29.76
Open Price 76.35
Prev Close 76.1

View All Metrics

Zenotech Laboratories Analysis

Risk Meter

50% Low risk
50% Moderate risk
50% Balanced Risk
50% High risk
50% Extreme risk

Zenotech Laboratories News

Premium

Zenotech Laboratories Q3 FY24 Results Live: Profit Rises by 143.21% YoY

1 min read . 31 Jan 2024

On Wednesday, the BSE Sensex tanked 774 points to 60,205, while the Nifty50 plunged 226 points to 17,892.

Premium

Stocks to Watch: Adani Enterprises, Bajaj Finance, Maruti Suzuki, Tata Motors

3 min read . 27 Jan 2023

Individually, Mahindra Lifespace Developers plans to garner up to Rs 300 crore by way of issue of equity shares to the existing shareholders. Photo: Hindustan Times

Premium

Four companies file papers with Sebi to raise about Rs700 crore

1 min read . 02 Mar 2017

Ranbaxy owns 46.84% in Zenotech, while Japan’s Daiichi Sankyo holds 20%, according to a BSE data. Photo: Mint

Premium

Zenotech shares hit upper circuit on Sun Pharma’s open offer

1 min read . 31 Mar 2015

View More News

Zenotech Laboratories Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
40.83

Selling/ General/ Admin Expenses Total
9.46

Depreciation/ Amortization
7.09

Other Operating Expenses Total
14.15

Total Operating Expense
30.7

Operating Income
10.14

Net Income Before Taxes
11.14

Net Income
8.3

Diluted Normalized EPS
1.36

Period
2023

Total Revenue
42.42

Selling/ General/ Admin Expenses Total
17.97

Depreciation/ Amortization
7.17

Other Operating Expenses Total
0.18

Total Operating Expense
28.89

Operating Income
13.53

Net Income Before Taxes
14.5

Net Income
11.59

Diluted Normalized EPS
1.89

Period
2022

Total Revenue
36.57

Selling/ General/ Admin Expenses Total
16.4

Depreciation/ Amortization
6.97

Other Operating Expenses Total
0.14

Total Operating Expense
26.08

Operating Income
10.49

Net Income Before Taxes
9.9

Net Income
22.18

Diluted Normalized EPS
3.63

Period
2021

Total Revenue
19.37

Selling/ General/ Admin Expenses Total
13.54

Depreciation/ Amortization
6.46

Other Operating Expenses Total
-2.94

Total Operating Expense
19.45

Operating Income
-0.08

Net Income Before Taxes
-1.22

Net Income
-1.22

Diluted Normalized EPS
-0.2

Period
2020

Total Revenue
25.94

Selling/ General/ Admin Expenses Total
14.14

Depreciation/ Amortization
4.85

Other Operating Expenses Total
0.03

Total Operating Expense
15.44

Operating Income
10.5

Net Income Before Taxes
10.78

Net Income
10.78

Diluted Normalized EPS
0.79

Period
2019

Total Revenue
13.03

Selling/ General/ Admin Expenses Total
13.99

Depreciation/ Amortization
4.2

Other Operating Expenses Total
-0.01

Total Operating Expense
20.49

Operating Income
-7.46

Net Income Before Taxes
-3.13

Net Income
-3.13

Diluted Normalized EPS
-0.51

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Zenotech Laboratories Technical

Moving Average SMA

5 Day78.37
10 Day81.51
20 Day81.07

50 Day87.71
100 Day76.84
300 Day71.32

Zenotech Laboratories Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Zim Laboratories
102.9
-1.4
-1.34
131.3
89.9
501.39

Kilitch Drugs India
309.3
-1.75
-0.56
469.85
298.45
497.43

Zenotech Laboratories
76.2
0.1
0.13
107.79
52.23
465.05

Gennex Laboratories
18.96
-0.26
-1.35
29
13.25
431.24

Venus Remedies
297.15
2.65
0.9
429.6
280
397.29

Zenotech Laboratories Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

23-Oct-24
Quarterly Results

26-Jul-24
Quarterly Results

01-May-24
Audited Results

29-Jan-24
Quarterly Results

30-Oct-23
Quarterly Results

01-Aug-23
Quarterly Results

28-Apr-23
Audited Results

27-Jan-23
Quarterly Results

28-Oct-22
Quarterly Results

22-Jul-22
Quarterly Results

Meeting Date
Announced on
Purpose

29-Sept-23
01-Aug-23
AGM

23-Jun-22
20-May-22
POM

View All

Company Profile

ABOUT Zenotech Laboratories

Industry Biotechnology & Drugs
ISIN INE486F01012
BSE Code 532039

Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.

MANAGEMENT

Sachin Gavandare Chief Executive Officer
K.V. Poly Chief Financial Officer
Abdul Gafoor Mohammad Chief Compliance Officer, Company Secretary

ZENOTECH LABORATORIES SUMMARY

Zenotech Laboratories is trading 0.13% upper at Rs 76.20 as compared to its last closing price. Zenotech Laboratories has been trading in the price range of 77.9 & 74.5.

The company posted a net profit of 1.35 Crores in its last quarter.

Listed peers of Zenotech Laboratories include Zim Laboratories (-1.34%), Kilitch Drugs India (-0.56%), Zenotech Laboratories (0.13%) etc.

Zenotech Laboratories has a 68.84% promoter holding & 31.16% public holding.

FAQs about Zenotech Laboratories

Zenotech Laboratories is trading at 76.20 as on 21 Nov, 2024 3:06:52 PM. This is 0.13% upper as compared to its previous closing price of 76.1

The market capitalization of Zenotech Laboratories is - as on 21 Nov, 2024 3:06:52 PM.

The 52 wk high for Zenotech Laboratories is 107.79 whereas the 52 wk low is 52.23

Zenotech Laboratories can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 29.76
Dividend Yield: -
D/E ratio: -

Zenotech Laboratories reported a net profit of 8.3 Cr in 2024.

Zenotech Laboratories Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Zenotech Laboratories Share Price

Price Range

Key Metrics

Zenotech Laboratories Analysis

Zenotech Laboratories News

Zenotech Laboratories Q3 FY24 Results Live: Profit Rises by 143.21% YoY

Stocks to Watch: Adani Enterprises, Bajaj Finance, Maruti Suzuki, Tata Motors

Four companies file papers with Sebi to raise about Rs700 crore

Zenotech shares hit upper circuit on Sun Pharma’s open offer

Zenotech Laboratories Financials

Forecast

Forecast

Forecast

Zenotech Laboratories Technical

Zenotech Laboratories Peers

Zenotech Laboratories Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Zenotech Laboratories

MANAGEMENT

ZENOTECH LABORATORIES SUMMARY

FAQs about Zenotech Laboratories

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue